Professor and Chief Physician, InFLAMES group leader Pirjo Nuutila is receiving the 2022 Novo Nordisk Foundation Lecture prize for her contribution to research on metabolic diseases such as overweight and diabetes.
InFLAMES (Innovation Ecosystem based on the Immune System) is a Finnish research flagship that aims at identifying novel drug targets using the most modern technological platforms and finding novel diagnostic tools to identify the patients benefitting from personalised therapies.
InFLAMES (Innovation Ecosystem based on the Immune System) is a Finnish research flagship that aims at identifying novel drug targets using the most modern technological platforms and finding novel diagnostic tools to identify the patients benefitting from personalised therapies.
InFLAMES (Innovation Ecosystem based on the Immune System) is a Finnish research flagship that aims at identifying novel drug targets using the most modern technological platforms and finding novel diagnostic tools to identify the patients benefitting from personalised therapies.
InFLAMES (Innovation Ecosystem based on the Immune System) is a Finnish research flagship that aims at identifying novel drug targets using the most modern technological platforms and finding novel diagnostic tools to identify the patients benefitting from personalised therapies.
Professor Hans Clevers, Professor Henning Walczak and Professor Christopher Chen will join the InFLAMES Flagship as visiting professors and lend their expertise to strengthen the Turku-based research and innovation endeavor.
The InFLAMES Flagship (Innovation Ecosystem based on the Immune System) is a joint effort of University of Turku and Åbo Akademi University aiming at being an internationally recognized, top-level, immunological research and development cluster which will be globally attractive both for the researchers and business partners.
The doctoral module of the InFLAMES Flagship (Innovation Ecosystem based on the Immune System) offers immunological and immunology-related education to the Doctoral Reseachers in the Flagship. On this website you can find information regarding the contents, completion and application process of the doctoral module.
Please note that many of the practicalities regarding the module are still being finalized and these sites are expected to be updated frequently.
Researchers at the University of Turku, Finland, showed that the antibody treatment reactivates the immune defense in patients with advanced-stage cancer. The treatment alters the function of the body’s phagocytes and facilitates extensive activation of the immune system.
Although vaccination programmes against pertussis are very effective in Europe, new Finnish study shows that the disease is still very common among middle-aged adults in various European countries. At the same time, the results show that the disease is underdiagnosed as the annually reported figures are considerably lower than those discovered in the study.